Medicare to boost payment for certain diagnostic imaging agents
Radiology Business
NOVEMBER 5, 2024
CMS is moving forward with a proposal to issue separate reimbursement for radiopharmaceuticals—a change long lobbied for by the imaging industry.
Diagnostic Imaging Radiology Radiopharmaceuticals 
279 
Generative AI, radiologist shortages feature in 2024 Minnies
AuntMinnie
NOVEMBER 12, 2024
With 100% of precincts now reporting, we’re finally ready to declare this year’s winners in our annual awards program recognizing excellence in radiology. The voters also zeroed in on the ongoing shortage of radiologists as the Biggest Threat to Radiology. Most Influential Radiology Researcher Minnies 2024 Winner: Erik H.
Join 5,000
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
The rise of theranostics: Part 3 -- What is a theranostics center?
AuntMinnie
JUNE 3, 2024
With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.
The rise of theranostics: Part 5 -- Advice from center administrators
AuntMinnie
JULY 12, 2024
As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. Theranostics offers hospital radiology departments the opportunity to keep more reimbursement dollars in the department, Beyder explained.
Meet the Minnies 2024 finalists
AuntMinnie
OCTOBER 25, 2024
Who made it to the final round in the 2024 edition of the Minnies, AuntMinnie.com 's event recognizing excellence in radiology? Most Influential Radiology Researcher Erik Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik Middlebrooks, MD. There's a huge role for AI in image acquisition," he said. Perry Pickhardt, MD.
The rise of theranostics: Part 1 -- Gaining momentum
AuntMinnie
MARCH 26, 2024
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.
Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer
Imaging Technology
JULY 9, 2024
Campione also joins the Blue Earth Diagnostics Ltd. “I Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., Bracco Imaging S.p.A.,
Let's personalize your content